Palisade Capital Management LLC Emergent Bio Solutions Inc. Transaction History

Palisade Capital Management LLC

$3.22 Billion
Q3 2024

A detailed history of Palisade Capital Management LLC transactions in Emergent Bio Solutions Inc. stock. As of the latest transaction made, Palisade Capital Management LLC holds 749,930 shares of EBS stock, worth $6.2 Million. This represents 0.19% of its overall portfolio holdings.

Number of Shares

749,930

Previous 453,829 65.25%

Holding current value

$6.2 Million

Previous $3.1 Million 102.29%

% of portfolio

0.19%

Previous 0.1%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$5.72 - $14.77 $1.69 Million - $4.37 Million	296,101 Added 65.25%	749,930 $6.26 Million
Q2 2024 Aug 14, 2024	SELL	$1.86 - $6.98 $14,543 - $54,576	-7,819 Reduced 1.69%	453,829 $3.1 Million
Q1 2024 May 15, 2024	BUY	$1.5 - $3.41 $16,854 - $38,314	11,236 Added 2.49%	461,648 $1.17 Million
Q4 2023 Feb 14, 2024	SELL	$1.82 - $3.16 $107,221 - $186,165	-58,913 Reduced 11.57%	450,412 $1.08 Million
Q3 2023 Nov 14, 2023	SELL	$3.17 - $7.91 $92,224 - $230,125	-29,093 Reduced 5.4%	509,325 $1.73 Million
Q2 2023 Aug 14, 2023	BUY	$7.35 - $13.21 $180,420 - $324,265	24,547 Added 4.78%	538,418 $3.96 Million
Q1 2023 May 08, 2023	BUY	$7.79 - $16.29 $95,030 - $198,721	12,199 Added 2.43%	513,871 $5.32 Million
Q4 2022 Feb 14, 2023	SELL	$11.0 - $21.45 $278,487 - $543,049	-25,317 Reduced 4.8%	501,672 $5.92 Million
Q3 2022 Nov 14, 2022	SELL	$20.09 - $35.8 $785,338 - $1.4 Million	-39,091 Reduced 6.91%	526,989 $11.1 Million
Q2 2022 Aug 10, 2022	BUY	$27.42 - $43.63 $155,498 - $247,425	5,671 Added 1.01%	566,080 $17.6 Million
Q1 2022 May 09, 2022	SELL	$36.48 - $52.22 $895,511 - $1.28 Million	-24,548 Reduced 4.2%	560,409 $23 Million
Q4 2021 Feb 10, 2022	SELL	$33.11 - $55.01 $1.94 Million - $3.22 Million	-58,507 Reduced 9.09%	584,957 $25.4 Million
Q3 2021 Nov 15, 2021	BUY	$50.07 - $66.05 $2.05 Million - $2.71 Million	40,984 Added 6.8%	643,464 $32.2 Million
Q2 2021 Aug 12, 2021	SELL	$56.61 - $80.46 $1.33 Million - $1.89 Million	-23,489 Reduced 3.75%	602,480 $38 Million
Q1 2021 May 12, 2021	BUY	$86.23 - $125.19 $4.05 Million - $5.88 Million	46,960 Added 8.11%	625,969 $58.2 Million
Q4 2020 Feb 11, 2021	BUY	$79.17 - $111.47 $11.9 Million - $16.7 Million	150,134 Added 35.01%	579,009 $51.9 Million
Q3 2020 Nov 12, 2020	BUY	$81.91 - $134.94 $4.82 Million - $7.94 Million	58,825 Added 15.9%	428,875 $44.3 Million
Q2 2020 Aug 06, 2020	BUY	$54.33 - $89.52 $9.21 Million - $15.2 Million	169,448 Added 84.47%	370,050 $29.3 Million
Q1 2020 May 13, 2020	BUY	$49.34 - $68.76 $3.73 Million - $5.2 Million	75,686 Added 60.59%	200,602 $11.6 Million
Q4 2019 Feb 04, 2020	BUY	$51.21 - $59.06 $6.4 Million - $7.38 Million	124,916 New	124,916 $6.74 Million

Others Institutions Holding EBS

# of Institutions

159

Shares Held

33.7M

Call Options Held

453K

Put Options Held

931K

View Full List

About Emergent BioSolutions Inc.

Ticker EBS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,861,500
Market Cap $412M
Description
Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...

More about EBS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Palisade Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Palisade Capital Management LLC with notifications on news.

Account

Palisade Capital Management LLC Emergent Bio Solutions Inc. Transaction History